Ictal lack of binding to brain parenchyma suggests integrity of the blood–brain barrier for11C-dihydroergotamine during glyceryl trinitrate-induced migraine

Therapeutic prospects for migraine: Can paradise be regained?

(2013) Peter J. Goadsby   ANNALS OF NEUROLOGY

Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks

(2013) Farooq Husain Maniyar et al.   BRAIN

The International Classification of Headache Disorders, 3rd edition (beta version)

(2013)   CEPHALALGIA

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

(2011) David J Hewitt et al.   CEPHALALGIA

A Systematic Review of the Factors Affecting Accuracy of SUV Measurements

(2010) Michael C. Adams et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Current practice and future directions in the prevention and acute management of migraine

(2010) Peter J Goadsby et al.   LANCET NEUROLOGY

CGRP and its receptors provide new insights into migraine pathophysiology

(2010) Tony W. Ho et al.   Nature Reviews Neurology

Matrix metalloproteinases during and outside of migraine attacks without aura

(2009) M Ashina et al.   CEPHALALGIA

A Pilot Study to Assess the Efficacy of Tariquidar to Inhibit P-glycoprotein at the Human Blood-Brain Barrier with (R)-11C-Verapamil and PET

(2009) C. C. Wagner et al.   JOURNAL OF NUCLEAR MEDICINE

The Blood-Brain Barrier in Migraine Treatment

(2008) L Edvinsson et al.   CEPHALALGIA

Early vs. Non-Early Intervention in Acute Migraine — ‘Act When Mild (AwM)’. A Double-Blind, Placebo-Controlled Trial of Almotriptan

(2008) PJ Goadsby et al.   CEPHALALGIA